Compare VanEck Vietnam ETF (VNM) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
VanEck Vietnam ETF vs GeneDx Holdings Corp — how do they compare? VanEck Vietnam ETF trades at $16.92, while GeneDx Holdings Corp trades at $61.92 (market cap $1.80B). The key difference: VanEck Vietnam ETF is trading nearer its 52-week high, GeneDx Holdings Corp nearer its low. Which is the better fit depends on your goals.
| VNM | WGS | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $19.80 | $167.51 |
52-Week Low | $15.35 | $34.51 |
Market Cap | — | $1.80B |
Enterprise Value | — | $1.80B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
VNM trades at $16.84, down 2.88% on the day, reflecting a bearish technical trend with moving averages signaling strong selling pressure. The stock's current price is at a key support level of $17, with oversold RSI readings suggesting potential for a near-term bounce. Recent news highlights challenges including underperformance relative to other emerging markets and strain on Vietnam's power grid due to extreme weather.
The outlook remains cautious due to macroeconomic headwinds and geopolitical risks affecting Vietnam's market. Investment opportunity hinges on potential foreign institutional inflows following FTSE Russell's EM reclassification in September 2026. Key risks include sustained underperformance, regional instability, and domestic infrastructure pressures.
GeneDx Holdings (WGS) trades at $60.65, down 4.46% today, amid a bearish technical signal and multiple class-action lawsuits alleging securities fraud. The stock shows weak fundamentals with a negative net income margin of -17.58% and ROE of -30.42%, though it beat EPS estimates in two of the last three quarters. Revenue grew to $427.54M in 2025 but profitability remains a challenge, with a high EV/EBITDA of 161.17 indicating stretched valuation relative to earnings.
Despite a 90.9% analyst buy rating and a $75.40 consensus price target, significant risks from litigation and persistent losses cloud the outlook. The stock faces near-term pressure from legal overhangs, while operational cash flow turned negative in 2026. Investors should weigh high analyst optimism against substantial fundamental and legal headwinds before considering a position.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About VanEck Vietnam ETF
VNM is the first and largest U.S.-listed ETF providing targeted exposure to the Vietnamese equity market. It tracks the MarketVector™ Vietnam Local Index, which includes publicly traded companies that are locally incorporated in Vietnam. It serves as a liquid, transparent vehicle for investors looking to participate in Vietnam's transition into a global manufacturing hub and its long-term potential for emerging market reclassification.
Read more on VNM →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
